Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Anti-Obesity Prescription Drugs Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global Anti-Obesity Prescription Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anti-Obesity Prescription Drugs in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Anti-Obesity Prescription Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
F Hoffmann La Roche
Arena Pharmaceuticals
Orexigen Therapeutics
Phentermine and Topiramate
VIVUS, Inc
Liraglutide
Bupropion and Naltrexone
Orlistat
Bupropion and Naltrexone
Novo Nordisk
Lorcaserin
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oral Medicine
Diet Patch
Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals Pharmacies
Retail Pharmacies
E-commerce

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global Anti-Obesity Prescription Drugs Market Research Report 2017
1 Anti-Obesity Prescription Drugs Market Overview
1.1 Product Overview and Scope of Anti-Obesity Prescription Drugs
1.2 Anti-Obesity Prescription Drugs Segment by Type (Product Category)
1.2.1 Global Anti-Obesity Prescription Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
1.2.2 Global Anti-Obesity Prescription Drugs Production Market Share by Type (Product Category) in 2016
1.2.3 Oral Medicine
1.2.4 Diet Patch
1.2.5 Other
1.3 Global Anti-Obesity Prescription Drugs Segment by Application
1.3.1 Anti-Obesity Prescription Drugs Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-commerce
1.4 Global Anti-Obesity Prescription Drugs Market by Region (2012-2022)
1.4.1 Global Anti-Obesity Prescription Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Anti-Obesity Prescription Drugs (2012-2022)
1.5.1 Global Anti-Obesity Prescription Drugs Revenue Status and Outlook (2012-2022)
1.5.2 Global Anti-Obesity Prescription Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Anti-Obesity Prescription Drugs Market Competition by Manufacturers
2.1 Global Anti-Obesity Prescription Drugs Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Anti-Obesity Prescription Drugs Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Anti-Obesity Prescription Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Anti-Obesity Prescription Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Anti-Obesity Prescription Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Anti-Obesity Prescription Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti-Obesity Prescription Drugs Market Competitive Situation and Trends
2.5.1 Anti-Obesity Prescription Drugs Market Concentration Rate
2.5.2 Anti-Obesity Prescription Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Obesity Prescription Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Anti-Obesity Prescription Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Anti-Obesity Prescription Drugs Production and Market Share by Region (2012-2017)
3.3 Global Anti-Obesity Prescription Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Anti-Obesity Prescription Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Anti-Obesity Prescription Drugs Consumption by Region (2012-2017)
4.2 North America Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Anti-Obesity Prescription Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Anti-Obesity Prescription Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Anti-Obesity Prescription Drugs Production and Market Share by Type (2012-2017)
5.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Anti-Obesity Prescription Drugs Price by Type (2012-2017)
5.4 Global Anti-Obesity Prescription Drugs Production Growth by Type (2012-2017)

6 Global Anti-Obesity Prescription Drugs Market Analysis by Application
6.1 Global Anti-Obesity Prescription Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Anti-Obesity Prescription Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Anti-Obesity Prescription Drugs Manufacturers Profiles/Analysis
7.1 F Hoffmann La Roche
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 F Hoffmann La Roche Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Arena Pharmaceuticals
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Orexigen Therapeutics
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Phentermine and Topiramate
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Phentermine and Topiramate Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 VIVUS, Inc
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 VIVUS, Inc Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Liraglutide
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Liraglutide Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Bupropion and Naltrexone
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Bupropion and Naltrexone Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Orlistat
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Orlistat Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Bupropion and Naltrexone
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Bupropion and Naltrexone Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Novo Nordisk
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Anti-Obesity Prescription Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Novo Nordisk Anti-Obesity Prescription Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Lorcaserin

8 Anti-Obesity Prescription Drugs Manufacturing Cost Analysis
8.1 Anti-Obesity Prescription Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti-Obesity Prescription Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Anti-Obesity Prescription Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-Obesity Prescription Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Anti-Obesity Prescription Drugs Market Forecast (2017-2022)
12.1 Global Anti-Obesity Prescription Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Anti-Obesity Prescription Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Anti-Obesity Prescription Drugs Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Anti-Obesity Prescription Drugs Price and Trend Forecast (2017-2022)
12.2 Global Anti-Obesity Prescription Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Anti-Obesity Prescription Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Anti-Obesity Prescription Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Anti-Obesity Prescription Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 24 hours.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37945

Category: 16

Published date: 2017-12-03 20:12:16

Number of Pages: 111

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)